Login
← Go Back
Sanofi India
SANOFI · Pharma > Pharmaceuticals & Drugs · Chairman: Aditya Narayan · MD: Rajaram Narayanan · Listing date: Oct. 24, 1994 · Employees: 2912 · Mumbai · http://www.sanofiindialtd.com
Stock Price vs Company Growth
1d
1.2%
1w
1.2%
1m
5.7%
3m
10.6%
6m
30.8%
1y
29.8%
5y
8.3%
10y
3.2%
all
8.8%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 4,143 1.2%
4,050
4,819
Company Overview
Sales
2,235 Cr
Growth: -5.4%
Profit after Tax
405 Cr
Growth: -11.8%
Mid Cap
9,541 Cr
P/E: 23.1x
Industry P/E: 33.1x
Fundamentals
Sales (Cr) ₹ 2,235
Growth -5.4%
EBITDA 25.6%
P/S 4.3x
Dividend 1.3%
P/E 23.1x
Book Value ₹ 374
PEG Ratio -4.3x
ROE 35.2%
P/B 11.1x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
4.9 %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Frontline Equity Fund
2.7 %
Nippon Life India Trustee Ltd-A/C Nippon India Growth Fund
1.78 %
Uti-Mastershare Unit Scheme
1.64 %
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund
1.36 %
Promoters
Hoechst Gmbh
60.37 %
Sanofi
0.02 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. The company prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. The company stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
Belongs to (12 Indices) view more
Investors (53)
sbi.magn...
icici.pr...
birla.su...
Followers (11)
nitin2
keerthi
deepak